电子医生通知促进重度主动脉瓣狭窄识别与管理:一项随机临床试验
本研究为多中心实用整群随机临床试验,纳入285名曾开具经胸超声心动图且发现可能指示重度主动脉瓣狭窄(主动脉瓣面积≤1.0 cm²)的医生,随机分为电子医生通知组与常规护理组。主要终点为指数超声后1年内接受主动脉瓣置换的比例。结果显示电子通知组1年内主动脉瓣置换率显著高于常规护理组(48.2% vs 37.2%,OR 1.62,95%CI 1.13-2.32,P=0.009),在有症状患者中同样显著(60.7% vs 46.5%,OR 1.77,95%CI 1.17-2.65,P=0.006),并减少了性别和年龄差异,改善了生存时间。
要点
- 电子医生通知可提高重度主动脉瓣狭窄患者1年内主动脉瓣置换率。
- 电子通知在有症状患者、女性、80岁以上及住院期间超声患者中效果更明显。
- 电子通知与1年内限制性平均生存时间延长相关。
核心结论
- 电子医生通知增加了重度主动脉瓣狭窄患者1年内主动脉瓣置换率。
- 电子通知减少了主动脉瓣置换使用的性别和年龄差异。
- 电子通知改善了重度主动脉瓣狭窄患者的生存时间。
研究设计与样本
- 多中心学术健康系统内开展的实用整群随机临床试验,2022年3月至2023年11月。
- 纳入285名曾开具经胸超声心动图且发现可能指示重度主动脉瓣狭窄(主动脉瓣面积≤1.0 cm²)的医生。
- 医生随机分为电子通知组(144名,对应496例患者)和常规护理组(141名,对应443例患者)。
主要发现
- 1年内主动脉瓣置换率电子通知组为48.2%,常规护理组为37.2%(OR 1.62,95%CI 1.13-2.32,P=0.009)。
- 有症状患者中1年内主动脉瓣置换率电子通知组为60.7%,常规护理组为46.5%(OR 1.77,95%CI 1.17-2.65,P=0.006)。
- 80岁以上患者中电子通知组OR为2.00(95%CI 1.17-3.41,P=0.01)。
- 女性患者中电子通知组OR为2.78(95%CI 1.69-4.57,P<0.001)。
- 住院期间指数超声患者中电子通知组OR为2.49(95%CI 1.44-4.31,P<0.001)。
临床怎么用
- 对于超声心动图提示重度主动脉瓣狭窄(主动脉瓣面积≤1.0 cm²)的患者,电子医生通知可作为一种简单、可扩展的干预措施,提高临床医生对关键超声发现的认知。
- 电子通知可促进主动脉瓣置换的评估与实施,尤其使女性、高龄及住院患者获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Symptomatic severe aortic stenosis (AS) remains undertreated with high resultant mortality despite increased growth and availability of aortic valve replacement (AVR) since the advent of transcatheter therapies. We evaluate the impact of electronic provider notifications (EPNs) on rates of AVR at 1 year. METHODS: In a pragmatic cluster randomized clinical trial conducted within a multicenter academic health system from March 2022 through November 2023, 285 providers who had ordered a transthoracic echocardiogram (TTE) with findings potentially indicative of severe AS with an aortic valve area ≤1.0 cm2 were enrolled. Providers were randomly assigned to receive EPNs for each of their patients with severe AS on TTE or to usual care. Notifications highlighted the detection of severe AS and included patient-specific clinical guideline recommendations for its management. The primary end point was the proportion of patients with severe AS receiving AVR within 1 year of the index TTE. RESULTS: A total of 144 providers were randomized to intervention and 141 to control, resulting in 496 and 443 patients assigned to each group, respectively. The patient cohort had mean age of 77±11 years, was 47% female, and had a mean aortic valve area of 0.8±0.1 cm2. Rates of AVR within 1 year were 48.2% with EPNs versus 37.2% with usual care (odds ratio [OR], 1.62 [95% CI, 1.13-2.32]; P=0.009]) and 60.7% and 46.5%, respectively, among symptomatic patients (OR, 1.77 [95% CI, 1.17-2.65]; P=0.006). Notification treatment effect was highest with EPNs for patients >80 years of age (OR, 2.00 [95% CI, 1.17-3.41]; P=0.01), for women (OR, 2.78, [95% CI, 1.69-4.57]; P<0.001), and when the index TTE was performed within the inpatient setting (OR, 2.49 [95% CI, 1.44-4.31]; P<0.001). Within 1 year, the restricted mean survival time was longer with EPNs in all (12 days; P=0.04) and symptomatic patients (23 days; P=0.01). CONCLUSIONS: In this first study of EPNs for valvular heart disease, EPNs increased rates of AVR for severe AS, lessened sex and age disparities in AVR use, and improved survival time. EPNs may be a simple, scalable intervention to raise awareness of critical TTE findings and improve the quality of care for patients with severe AS. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT05230225.
引用
- Tanguturi VK, Abou-Karam R, Cheng F, et al. Electronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: A Randomized Clinical Trial. Circulation. 2025. PMID: 40159132. doi:10.1161/CIRCULATIONAHA.125.074470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。